Alyeska Investment Group, L.P. - ACHILLES THERAPEUTICS PLC ownership

ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 31 filers reported holding ACHILLES THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$239,000
-20.6%
30,7300.0%0.00%0.0%
Q2 2021$301,000
-43.5%
30,730
-4.7%
0.00%
-57.1%
Q1 2021$533,00032,2300.01%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$55,545,00053.06%
RA Capital Management 5,014,687$25,124,0000.44%
Artal Group S.A. 2,255,375$11,299,0000.31%
Redmile Group, LLC 2,088,089$10,461,0000.24%
Orbimed Advisors 1,584,845$7,940,0000.10%
Sender Co & Partners, Inc. 27,690$139,0000.07%
Baker Brothers Advisors 2,591,366$12,983,0000.06%
Perceptive Advisors 1,510,750$7,568,0000.06%
Woodline Partners LP 324,387$1,625,0000.02%
Point72 Asset Management, L.P. 1,000,000$5,010,0000.02%
View complete list of ACHILLES THERAPEUTICS PLC shareholders